TGFB1 and neoplasm: In our previous study on a large cohort of OC samples, we demonstrated differential expression of TGFβ receptor splice variants in the different anatomical sites of the disease and that effusion-derived tumor cells did not show Smad activation as part of the TGFβ canonical pathway [13].